Key result
Dual-energy lattice-tip CTI ablation achieves acute success with 0% lead dislodgement or CIED malfunction.
Why the study?
Data on the safety of the dual-energy lattice-tip catheter for CTI ablation remain limited in patients with CIEDs, where ablation near leads poses potential risks.
Is cavotricuspid isthmus ablation using a dual-energy lattice-tip catheter safe and feasible in patients with cardiac implantable electronic devices?
Observational (n=67)
No
Is cavotricuspid isthmus ablation using a dual-energy lattice-tip catheter safe and feasible in patients with cardiac implantable electronic devices?
CTI ablation using a dual-energy lattice-tip catheter appears safe and acutely effective in patients with CIEDs, without causing lead dislodgement or device malfunction.
May offer alternative for CTI ablation near CIED leads; leaves open safety and efficacy in larger studies.
Background Cavotricuspid isthmus (CTI) ablation is a standard therapy for typical atrial flutter. In patients with cardiac implantable electronic devices (CIEDs), ablation near intracardiac leads may present risks, including lead dislodgement, thermal injury, or electromagnetic interference. The dual‐energy lattice‐tip catheter, capable of delivering both pulsed field ablation (PFA) and radiofrequency (RF) energy, is a novel device designed for CTI ablation and pulmonary vein isolation (PVI). However, data on its safety in patients with CIEDs remain limited. Objectives This study aimed to evaluate procedural safety and short‐term device performance of CTI ablation using the dual‐energy lattice‐tip catheter in patients with CIEDs. Methods We conducted a retrospective, single‐center analysis of 67 consecutive patients with CIEDs who underwent CTI ablation during atrial fibrillation or atypical flutter ablation procedures, with the dual‐energy lattice‐tip catheter between January and October 2025. Baseline demographics, procedural details, and device interrogation data were collected. The primary outcome was procedural safety, including lead dislodgement, device malfunction, and major complications. Secondary outcomes included changes in lead sensing, pacing thresholds, and impedance from baseline to follow‐up. Results CTI ablation was acutely successful in all 67 patients. Combined RF and PF energy was used in 88% of cases. A total of 75 PFA applications and 158 RF lesions were delivered across the cohort. Patients received an average of 4.7 PFA applications and 9.9 RF lesions. No lead dislodgement or device malfunction occurred. Mean procedure time was 78.2 ± 10.8 min; mean fluoroscopy time was 2.75 ± 1.47 min. Three patients exhibited atrial sensing changes postablation, but all remained stable at follow‐up without the need for device reprogramming. Conclusions CTI ablation using a dual‐energy lattice‐tip catheter appears safe and feasible in patients with CIEDs. Larger prospective studies are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Hanna et al. (2026) conducted an observational in Atrial fibrillation or atypical flutter in patients with cardiac implantable electronic devices (n=67). Dual-energy lattice-tip catheter (pulsed field and radiofrequency ablation) was evaluated on Procedural safety, including lead dislodgement, device malfunction, and major complications. Cavotricuspid isthmus ablation using a dual-energy lattice-tip catheter was acutely successful in all 67 patients with CIEDs, with 0% incidence of lead dislodgement or device malfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: